Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Pointing a Finger at the Rich

Bill Bonner (August 25th, 2009) Writes:

Pity the poor rich! Pity the poor! Pity us all!

Here at the Daily Reckoning, we always take the part of the humble… the despised… the oppressed… and the misbegotten.

Today, that means the rich…

Yes, dear reader, the rich are getting beaten up. Maligned. Mistreated.

Their governments all have in it for them… taxes on ‘the rich’ are rising. In the US, the Democrats are talking about financing the entire nation’s health care system on the backs of the super-rich.

And their salaries are being targeted by prosecutors and politicians. No more million-dollar paydays… not with the feds looking over their shoulders. Oh… and their investment earnings are down too. The dividend yield on the stock market is scarcely 3% — try living on that, you rentiers! As for the 10-year T-note, the yield is only 3.5%.

And capital gains? Fugetaboutit. Stocks have been rallying (bouncing) since March 9 th. The

...

PennyOmega.com Stock Report! 8/07/09, MIPI, TEO, OYOG, AVAV, CTT, SPNG

Penny Omega (August 7th, 2009) Writes:

PennyOmega.com Stock Report!

PennyOmega.com Hot Stock News & Alerts!

signup3m

 

Friday August 7, 2009

PennyOmega.com Stock Report!

**************************************************************

Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) today announced that it has initiated a pivotal Phase 2 clinical trial for Azedra(TM) (Ultratrace(TM) Iobenguane I 131), its lead oncology candidate for the treatment of malignant pheochromocytoma, a type of neuroendocrine cancer. The single-arm trial will evaluate the efficacy and safety of Azedra in adult patients with malignant relapsed/refractory pheochromocytoma and position Molecular Insight to file a New Drug Application (NDA).

Telecom Argentina (NYSE: TEO), one of Argentina’s leading telecommunications groups, announced today Net Income of P$703 million for the six-month period ended June 30, 2009 or +15% when compared to the same

...

DrStockPick.com Stock Report! 8/04/09, VSEA, AMOT, SKH, GNBT, IWA, CVG

Dr. Stock Pick (August 4th, 2009) Writes:

DrStockPick.com Stock Report!

Tuesday August 4, 2009

signup3m

**************************************************************

Varian Semiconductor Equipment Associates, Inc. (NASDAQ: VSEA) today announced that the company will deliver a presentation at the 11th Annual Pacific Crest Technology Leadership Forum in Vail, Colorado on Tuesday, August 11, 2009 at 9:30 am mountain time.

Allied Motion Technologies Inc. (NASDAQ: AMOT) today announced it had a net loss for the quarter ended June 30, 2009 of $12,115,000 or $1.60 per diluted share compared to net income of $1,001,000 or $.13 per diluted share for the quarter ended June 30, 2008, a quarter in which the Company achieved record sales and profits. The loss includes a pretax asset impairment charge of $15,986,000 ($11,105,000

...
Tags for this Post:
11th Annual Pacific Crest Technology, Alan L. Wells, Allied Motion Technologies Inc., Amgen Inc., Boston, California, Chairman and Chief Executive Officer, Chief Financial Officer and Treasurer, Chief Scientific Advisor, Colorado, Convergys Corporation, Craig A. Knock, Dr Stock Pick, drug delivery, Generex Biotechnology Corporation, Government Sponsored Enterprises, Holzer Holzer & Fistel LLC, Internet Conference, Iowa Telecom, Iowa Telecommunications Services Inc., Joseph Rubinfeld, leader, loss mitigation services, Market Commentary, Massachusetts, Metabolic Diseases, one of the original founders, Oppenheimer & Co. Inc., relationship management solutions, relationship management;, Skilled Healthcare Group Inc, Sterling Home Retention Services, Stocks to Watch, synthetic vaccine platform technology programs, United States, United States District Court for the Central District o, USD, Vail, Varian Semiconductor Equipment Associates Inc., Vice President, www.generex.com

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.